Dr Mazereeuw and Colleagues Reply

Graham Mazereeuw^{1

2}, Krista L Lanctôt^{1

2

3}, Nathan Herrmann^{4

1

3}

Affiliations

¹ Neuropsychopharmacology Research Group, Hurvitz Brain Sciences Research Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
² Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
³ Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
⁴ nathan.herrmann@sunnybrook.ca.

Free article

Comment

Graham Mazereeuw et al. J Clin Psychiatry. 2016 Aug.

Free article

. 2016 Aug;77(8):e1006.

doi: 10.4088/JCP.16lr10666a.

Graham Mazereeuw^{1

2}, Krista L Lanctôt^{1

2

3}, Nathan Herrmann^{4

1

3}

¹ Neuropsychopharmacology Research Group, Hurvitz Brain Sciences Research Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
² Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
³ Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
⁴ nathan.herrmann@sunnybrook.ca.

No abstract available

Comment on

Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials.
O'Regan J, Lanctôt KL, Mazereeuw G, Herrmann N. O'Regan J, et al. J Clin Psychiatry. 2015 Nov;76(11):e1424-31. doi: 10.4088/JCP.14r09237. J Clin Psychiatry. 2015. PMID: 26646039
Pitfalls With the Unquestioning Use of Statistics.
Tan SM. Tan SM. J Clin Psychiatry. 2016 Aug;77(8):e1005. doi: 10.4088/JCP.16lr10666. J Clin Psychiatry. 2016. PMID: 27561142 No abstract available.